Christopher R. Green

Learn More
OBJECTIVE To investigate the frequency and longitudinal course of symptoms of depression, agitation, and psychosis in a longitudinally studied sample of patients with Alzheimer's disease (AD). DESIGN Longitudinal study of AD patients with follow-up assessments at 6-month intervals for an average of more than 3 years. SETTING Alzheimer's Disease Research(More)
OBJECTIVE To assess the reliability of activities of daily living (ADL) measures and determine the rate and pattern of longitudinal ADL change in patients with Alzheimer's disease (AD). DESIGN Longitudinal study with evaluations every 6 months. SETTING Alzheimer's Disease Research Center Clinics at Mount Sinai Medical Center, New York, and the Veterans(More)
This study sought to determine the relationship between behavioral disturbance and functional status in a longitudinally studied sample of patients with Alzheimer's disease (AD). One hundred and forty-nine patients meeting NINCDS-ADRDA criteria for probable AD were followed for an average of 37.3 months, with follow-up assessments every 6 months. Subjects(More)
The authors examined the role of cognitive-resource allocation in obtaining the often reported memory advantage for bizarre relative to common information by using the secondary-task method in 4 experiments. In Experiments 1 and 2, they investigated the relationship between differences in cognitive resource allocation during comprehension and in recall for(More)
Posttraumatic Stress Disorder (PTSD) is a prevalent, chronic, and disabling anxiety disorder that may develop following exposure to a traumatic event. The majority of individuals with PTSD often have comorbid psychiatric conditions such as major depression, generalized anxiety disorder, and substance use disorders, and are at increased risk for suicide.(More)
OBJECTIVE The purpose of this study was to examine the behavioural and cognitive effects of selegiline in a group of moderately behaviourally disturbed AD patients. DESIGN This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. SETTING An outpatient clinic in an urban-based tertiary referral centre in the(More)
  • 1